Refametinib (RDEA-119, BAY 86-9766) 25mg
Refametinib, also known as RDEA119, BAY 86-9766, is an orally bioavailable selective MEK inhibitor with potential antineoplastic activity.
| Trivial name | Refametinib (RDEA-119, BAY 86-9766) 25mg |
| Catalog Number | A12866-25 |
| Alternative Name(s) | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide |
| Molecular Formula | C19H20F3IN2O5S |
| CAS# | 923032-38-6 |
| SMILES | COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/refametinib-rdea-119-bay-86-9766.html |